Effects of Polymeric and Lipid Nanoparticle Self Amplifying RNA Formulation on Protein Expression and Vaccine Immunology, presented by Dr. Anna Blakney
|You may be asking, who is Dr Anna Blakney?|
Dr Anna Blakney, Assistant Professor at The University of British Columbia, a bioengineer who is most recently working as COVID vaccine scientist. She specialises in drug delivery systems for the treatment of various types of infectious diseases. But that’s not all, Anna is also a Tik Tok star with over 217K followers!!!
Don’t Miss these Topics discussed:
• What is Self amplifying RNA (saRNA)
• Formulation strategies: Polymeric and Lipid Nanoparticles
• Effect of formulation on protein expression and vaccine immunogenicity
Watch this presentation – Click here
NanoMedU Early Pre-clinical RNA Vaccines Training course
This course is aimed at providing pharmaceutical scientists with knowledge and confidence to start early preclinical development of RNA-LNP vaccines.
Part I – Fundamentals
This interactive, live virtual classroom session covers fundamentals of RNA-LNP formulations, self-assembly and RNA vaccines. Learn the importance of the 4 Pillars of RNA vaccine development, advantages and disadvantages of unmodified, base-modified and self-amplifying vectors and more.
Part 2 – Practical
Live guided instruction for preparing RNA-LNPs for early preclinical development. A NanoAssemblr® Ignite™ and the purchase of a GenVoy-ILM training kit and payload is required, in addition to the course cost. Successful completion of Part I is required.
If you would like further information regarding these courses or anything else related to lipid, polymer or hybrid nanoparticle formulations carrying small molecules, peptides nucleic acids (and more), please contact us